The drug development landscape has undergone a massive transformation in recent years, driven by advancements in bioprocessing and the rise of biologics. Compared to traditional small-molecule drugs, biologics differ significantly in terms of their production methods, molecular complexities and mechanisms of action.1 Their large size and elaborate ...
read more